Immunofluorescence
Immunofluorescence analysis of A549 cells, using SLC27A5 Antibody. The picture on the right is treated with the synthesized peptide.Western blot
Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue, using SLC27A5 Antibody. The picture on the right is treated with the synthesized peptide.Western blot analysis of extracts from HepG2 cells, using SLC27A5 Antibody. The lane on the right is treated with the synthesized peptide| Product Name | Rabbit anti-SLC27A5 polyclonal antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The antiserum was produced against synthesized peptide derived from human SLC27A5. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | WBIHCIFELISA |
| WB:1:500~1:1000 IHC:1:50~1:100 IF:1:100~1:500 ELISA:1:40000 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | S27A5 |
|---|---|
| Gene Synonyms | Bile acyl-CoA synthetase BACS Bile acid-CoA ligase BA-CoA ligase BAL Cholate--CoA ligase Very long-chain acyl-CoA synthetase homolog 2 VLCSH2 VLCS-H2 Very long-chain acyl-CoA synthetase-related protein VLACS-related VLACSR Fatty-acid-coenzyme A |
Immunofluorescence
Immunofluorescence analysis of A549 cells, using SLC27A5 Antibody. The picture on the right is treated with the synthesized peptide.
Western blot
Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue, using SLC27A5 Antibody. The picture on the right is treated with the synthesized peptide.Western blot analysis of extracts from HepG2 cells, using SLC27A5 Antibody. The lane on the right is treated with the synthesized peptide| Application Notes | WB:1:500~1:1000 IHC:1:50~1:100 IF:1:100~1:500 ELISA:1:40000 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
